Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crescita Therapeutics Inc (OP: CRRTF )

0.2999 UNCHANGED
Streaming Delayed Price Updated: 1:01 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2999
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2999
Today's Range 0.2999 - 0.2999
52wk Range 0.0559 - 0.5500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crescita to Acquire Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
Crescita Reports First Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire

Performance

YTD
-22.10%
-22.10%
1 Month
+436.49%
+436.49%
3 Month
N/A
N/A
6 Month
-22.10%
-22.10%
1 Year
-38.73%
-38.73%

More News

Read More
Crescita Reports Q4 and Fiscal 2023 Results
From Crescita Therapeutics
Via Business Wire
Crescita Reports Third Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Crescita Reports Second Quarter 2023 Results
From Crescita Therapeutics
Via Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Crescita Reports First Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
Crescita Reports Q4 and Fiscal 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Crescita Reports Third Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Crescita Reports Second Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Crescita Reports First Quarter 2022 Results
From Crescita Therapeutics
Via Business Wire
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
From Crescita Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.